Analyst: Powell May Not Provide Much Clarity
Karen Manna from Federated Hermes stated that Federal Reserve Chairman Powell might not satisfy investors' desire for clarity when he speaks to reporters after tomorrow's rate decision. The Federal Reserve is expected to keep rates unchanged, and Powell may face questions about the impact of tariffs on inflation and the economy. The final level and duration of the tariffs remain unknown, which limits Powell's ability to provide more clear information. "Forecasting is always fraught with difficulties, and making predictions in a constantly changing environment is almost impossible." She expects this uncertainty to persist until the Federal Reserve's June meeting, unless there is some substantial change.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

